MedTrace Logo

Outlook Quality of Life Intervention Study

NCT01044290 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2015-11-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether discussions of life story, forgiveness, and future goals improve quality of life for patients with serious illness.

Conditions

  • Cancer
  • Congestive Heart Failure (CHF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • End Stage Renal Disease (ESRD)

Interventions

OTHER

Life Completion

Subjects discussed life review, issues of forgiveness and heritage and legacy.

OTHER

Attention Control

Subjects listened to a non-guided relaxation CD

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Karen E. Steinhauser, PhD · Durham VA Medical Center HSR&D COE

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-02-28
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01044290 on ClinicalTrials.gov